[HTML][HTML] rapid response of refractory systemic lupus erythematosus skin manifestations to anifrolumab—a case-based review of clinical trial data suggesting a domain …
Systemic lupus erythematosus (SLE) is a clinically heterogeneous autoimmune disease,
and organ manifestations, such as lupus nephritis (LN) or skin disease, may be refractory to …
and organ manifestations, such as lupus nephritis (LN) or skin disease, may be refractory to …
Rapid Response of Refractory Systemic Lupus Erythematosus Skin Manifestations to Anifrolumab—A Case-Based Review of Clinical Trial Data Suggesting a Domain …
M Plüß, S Piantoni, C Wincup… - Journal of Clinical …, 2022 - search.ebscohost.com
Systemic lupus erythematosus (SLE) is a clinically heterogeneous autoimmune disease,
and organ manifestations, such as lupus nephritis (LN) or skin disease, may be refractory to …
and organ manifestations, such as lupus nephritis (LN) or skin disease, may be refractory to …
Rapid Response of Refractory Systemic Lupus Erythematosus Skin Manifestations to Anifrolumab—A Case-Based Review of Clinical Trial Data Suggesting a Domain …
M Plüß, S Piantoni, C Wincup… - Journal of Clinical …, 2022 - search.proquest.com
Systemic lupus erythematosus (SLE) is a clinically heterogeneous autoimmune disease,
and organ manifestations, such as lupus nephritis (LN) or skin disease, may be refractory to …
and organ manifestations, such as lupus nephritis (LN) or skin disease, may be refractory to …
Rapid Response of Refractory Systemic Lupus Erythematosus Skin Manifestations to Anifrolumab–A Case-Based Review of Clinical Trial Data Suggesting A Domain …
M Plüß, S Piantoni, C Wincup, P Korsten - 2022 - preprints.org
Systemic lupus erythematosus (SLE) is a clinically heterogeneous autoimmune disease,
and organ manifestations, such as lupus nephritis (LN) or skin disease, may be refractory to …
and organ manifestations, such as lupus nephritis (LN) or skin disease, may be refractory to …
[PDF][PDF] Rapid Response of Refractory Systemic Lupus Erythematosus Skin Manifestations to Anifrolumab—A Case-Based Review of Clinical Trial Data Suggesting a …
M Plüß, S Piantoni, C Wincup, P Korsten - J. Clin. Med - researchgate.net
Systemic lupus erythematosus (SLE) is a clinically heterogeneous autoimmune disease,
and organ manifestations, such as lupus nephritis (LN) or skin disease, may be refractory to …
and organ manifestations, such as lupus nephritis (LN) or skin disease, may be refractory to …
Rapid Response of Refractory Systemic Lupus Erythematosus Skin Manifestations to Anifrolumab-A Case-Based Review of Clinical Trial Data Suggesting a Domain …
M Plüß, S Piantoni, C Wincup… - Journal of Clinical …, 2022 - europepmc.org
Systemic lupus erythematosus (SLE) is a clinically heterogeneous autoimmune disease,
and organ manifestations, such as lupus nephritis (LN) or skin disease, may be refractory to …
and organ manifestations, such as lupus nephritis (LN) or skin disease, may be refractory to …
[HTML][HTML] Rapid Response of Refractory Systemic Lupus Erythematosus Skin Manifestations to Anifrolumab—A Case-Based Review of Clinical Trial Data Suggesting a …
M Plüß, S Piantoni, C Wincup… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
Systemic lupus erythematosus (SLE) is a clinically heterogeneous autoimmune disease,
and organ manifestations, such as lupus nephritis (LN) or skin disease, may be refractory to …
and organ manifestations, such as lupus nephritis (LN) or skin disease, may be refractory to …
[PDF][PDF] Rapid Response of Refractory Systemic Lupus Erythematosus Skin Manifestations to Anifrolumab–A Case-Based Review of Clinical Trial Data Suggesting A …
M Plüß, S Piantoni, C Wincup, P Korsten - 2022 - scholar.archive.org
Systemic lupus erythematosus (SLE) is a clinically heterogeneous autoimmune disease,
and organ manifestations, such as lupus nephritis (LN) or skin disease, may be refractory to …
and organ manifestations, such as lupus nephritis (LN) or skin disease, may be refractory to …
Rapid Response of Refractory Systemic Lupus Erythematosus Skin Manifestations to Anifrolumab—A Case-Based Review of Clinical Trial Data Suggesting a Domain …
M Plüß, S Piantoni, C Wincup, P Korsten - 2022 - publications.goettingen-research …
Systemic lupus erythematosus (SLE) is a clinically heterogeneous autoimmune disease,
and organ manifestations, such as lupus nephritis (LN) or skin disease, may be refractory to …
and organ manifestations, such as lupus nephritis (LN) or skin disease, may be refractory to …
Rapid Response of Refractory Systemic Lupus Erythematosus Skin Manifestations to Anifrolumab-A Case-Based Review of Clinical Trial Data Suggesting a Domain …
M Plüß, S Piantoni, C Wincup… - Journal of clinical …, 2022 - pubmed.ncbi.nlm.nih.gov
Systemic lupus erythematosus (SLE) is a clinically heterogeneous autoimmune disease,
and organ manifestations, such as lupus nephritis (LN) or skin disease, may be refractory to …
and organ manifestations, such as lupus nephritis (LN) or skin disease, may be refractory to …